These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1100214)

  • 1. Cucumber shaped and 35 nm particles in Creutzfeldt-Jakob disease.
    Horoupian DS; Ross RT
    Can J Neurol Sci; 1975 Aug; 2(3):203-7. PubMed ID: 1100214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of microglia and scrapie amyloid-immunoreactive plaques in kuru, Creutzfeldt-Jakob disease and Gerstmann-Sträussler syndrome.
    Guiroy DC; Wakayama I; Liberski PP; Gajdusek DC
    Acta Neuropathol; 1994; 87(5):526-30. PubMed ID: 8059606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.
    Namba Y; Tomonaga M; Kawasaki H; Otomo E; Ikeda K
    Brain Res; 1991 Feb; 541(1):163-6. PubMed ID: 2029618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubulovesicular structures in Creutzfeldt-Jakob disease.
    Liberski PP; Budka H; Sluga E; Barcikowska M; Kwiecinski H
    Acta Neuropathol; 1992; 84(3):238-43. PubMed ID: 1414277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphogenesis of amyloid plaques in mice with Creutzfeldt-Jakob disease.
    Hikita K; Tateishi J; Nagara H
    Acta Neuropathol; 1985; 68(2):138-44. PubMed ID: 3907258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubulovesicular structures in human and experimental Creutzfeldt-Jakob disease.
    Liberski PP; Budka H; Sluga E; Barcikowska M; Kwiecinski H
    Eur J Epidemiol; 1991 Sep; 7(5):551-5. PubMed ID: 1761114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies.
    Kitamoto T; Tateishi J; Tashima T; Takeshita I; Barry RA; DeArmond SJ; Prusiner SB
    Ann Neurol; 1986 Aug; 20(2):204-8. PubMed ID: 3092727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin immunoreactivity in kuru plaques in Creutzfeldt-Jakob disease.
    Suenaga T; Hirano A; Llena JF; Ksiezak-Reding H; Yen SH; Dickson DW
    Ann Neurol; 1990 Aug; 28(2):174-7. PubMed ID: 2171419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of Creutzfeldt-Jakob disease and Alzheimer's disease in the same patient.
    Brown P; Jannotta F; Gibbs CJ; Baron H; Guiroy DC; Gajdusek DC
    Neurology; 1990 Feb; 40(2):226-8. PubMed ID: 2405293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creutzfeldt-Jakob disease with severe involvement of cerebral white matter and cerebellum.
    Berciano J; Berciano MT; Polo JM; Figols J; Ciudad J; Lafarga M
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(6):533-8. PubMed ID: 2125393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is brain copper deficiency in Alzheimer's, Lewy body, and Creutzfeldt Jakob diseases the common key for a free radical mechanism and oxidative stress-induced damage?
    Deloncle R; Guillard O
    J Alzheimers Dis; 2015; 43(4):1149-56. PubMed ID: 25125459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive cortical spongiform changes with cerebellar small amyloid plaques: the clinicopathological case of MV2K+C subtype in Creutzfeldt-Jakob disease.
    Araki K; Nakano Y; Kobayashi A; Matsudaira T; Sugiura A; Takao M; Kitamoto T; Murayama S; Obi T
    Neuropathology; 2014 Dec; 34(6):541-6. PubMed ID: 24984899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
    Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
    Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation and common mechanism in Alzheimer's disease and prion amyloidosis: amyloid-associated proteins, neuroinflammation and neurofibrillary degeneration.
    Rozemuller AJ; Jansen C; Carrano A; van Haastert ES; Hondius D; van der Vies SM; Hoozemans JJ
    Neurodegener Dis; 2012; 10(1-4):301-4. PubMed ID: 22398730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical review of atypical cerebellum-type Creutzfeldt-Jakob disease: its relationship to "new variant" CJD and bovine spongiform encephalopathy.
    Narang HK
    Exp Biol Med (Maywood); 2001 Jul; 226(7):629-39. PubMed ID: 11444099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt-Jakob disease.
    Paquet C; Privat N; Kaci R; Polivka M; Dupont O; Haïk S; Laplanche JL; Hauw JJ; Gray F
    Acta Neuropathol; 2008 Nov; 116(5):567-73. PubMed ID: 18551298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electron microsocopy of brain amyloid plaques from a patient with new variant Creutzfeldt-Jakob disease.
    Fournier JG; Kopp N; Streichenberger N; Escaig-Haye F; Langeveld J; Brown P
    Acta Neuropathol; 2000 Jun; 99(6):637-42. PubMed ID: 10867797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creutzfeldt-Jakob disease.
    Manuelidis EE
    J Neuropathol Exp Neurol; 1985 Jan; 44(1):1-17. PubMed ID: 3880808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A special report I. Prion protein (PrP)--amyloid plaques in the transmissible spongiform encephalopathies, or prion diseases revisited.
    Liberski PP; Bratosiewicz J; Waliś A; Kordek R; Jeffrey M; Brown P
    Folia Neuropathol; 2001; 39(4):217-35. PubMed ID: 11928893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies.
    Richard M; Biacabe AG; Streichenberger N; Ironside JW; Mohr M; Kopp N; Perret-Liaudet A
    Acta Neuropathol; 2003 Mar; 105(3):296-302. PubMed ID: 12557018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.